Capitolis Liquid Global Markets LLC Acquires 150,000 Shares in CVS Health Corporation

The firm purchased $11.3 million worth of CVS stock in the third quarter.

Mar. 16, 2026 at 8:37am

Capitolis Liquid Global Markets LLC acquired a new position in shares of CVS Health Corporation (NYSE:CVS) during the third quarter, according to the company's recent 13F filing with the Securities and Exchange Commission. The firm acquired 150,000 shares of the pharmacy operator's stock, valued at approximately $11,308,000.

Why it matters

This acquisition by Capitolis Liquid Global Markets LLC represents a significant investment in CVS Health, one of the largest pharmacy chains in the United States. The move suggests the firm sees growth potential in CVS's business model and future prospects.

The details

Capitolis Liquid Global Markets LLC acquired the 150,000 shares of CVS Health as part of its investment strategy during the third quarter. The shares were valued at approximately $11.3 million, indicating the firm believes CVS stock is undervalued and has room for appreciation.

  • Capitolis Liquid Global Markets LLC acquired the 150,000 shares of CVS Health in the third quarter of 2026.

The players

Capitolis Liquid Global Markets LLC

An investment firm that acquired a new position in CVS Health Corporation.

CVS Health Corporation

A diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services, and health care solutions.

Got photos? Submit your photos here. ›

The takeaway

This investment by Capitolis Liquid Global Markets LLC in CVS Health Corporation suggests the firm sees significant growth potential in the pharmacy operator's business model and future prospects, despite some recent market volatility.